More regulatory doubts over CBD in US as FDA commissioner steps down

The resignation of Food and Drug Administration (FDA) commissioner Scott Gottlieb adds further uncertainty to the future of federal oversight of CBD in the US ...

Restricted content. Do you want to read more?